Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
Live Now : Nifty Banker 3.0 | India's First Retail Index Traders Online Conference.
Budget 2023
Budget 2023

Sun Pharma's profit, revenue to rise in Q3; EBITDA margin may remain stable

Brokerage firm Motilal Oswal Financial Services expects a 65.7 percent YoY rise in adjusted net profit and a 7.3 percent YoY rise in revenue for the quarter.

January 29, 2021 / 07:49 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Pharmaceutical major Sun Pharma is on January 29 expected to report a healthy year-on-year (YoY) rise in profit and revenue for the December quarter of the financial year 2020-21.

The company's EBITDA margin may remain stable or may even increase YoY but it may show a QoQ decline as partial cost-saving measures implemented during the lockdown unwind, brokerages said.

Along with the numbers, all eyes will be on prescription trends in specialty portfolio and the company's outlook on branded generics in emerging markets.

Brokerage firm Motilal Oswal Financial Services expects a 65.7 percent YoY rise in adjusted net profit and a 7.3 percent YoY rise in revenue for the quarter.